4//SEC Filing
Rosenblum Mark J 4
Accession 0001615219-20-000080
CIK 0001615219other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 8:55 PM ET
Size
5.4 KB
Accession
0001615219-20-000080
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Stock Option (right to buy)
2020-07-14+49,955→ 49,955 totalExercise: $1.32Exp: 2030-07-13→ Common Stock (49,955 underlying)
Footnotes (1)
- [F1]25% of the options are fully vested on July 14, 2021, and 1/36 of the remaining options vest on each monthly anniversary thereafter.
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001329154
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 8:55 PM ET
- Size
- 5.4 KB